霉浆菌检测市场规模、份额和成长分析（按产品、技术、应用、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球霉浆菌检测市场规模将达到 8.9733 亿美元，到 2025 年将成长至 9.6732 亿美元，到 2033 年将成长至 17.6409 亿美元，预测期（2026-2033 年将成长至 17.6409 亿美元，预测期（2026-2033 年）的复合年增长率为 7.8%。

由于製药和生物技术领域的污染案例不断增加，霉浆菌检测市场预计将迎来显着成长。活性化的监测活动和生物製药行业的需求正显着推动霉浆菌检测套组的需求。在新兴市场，医疗基础设施的改善、未被满足的医疗需求以及霉浆菌污染的高发生率均促进了这一成长。监管机构对生物製药和疫苗的严格检测要求进一步推动了生物製药行业的需求。此外，技术进步使得检测方法更加快速和准确，从而进一步扩大了市场。值得一提的创新包括高灵敏度检测技术，该技术提高了生物基质中的检测准确性，并进一步凸显了高效霉浆菌检测解决方案在业界的重要性。

推动全球霉浆菌检测市场发展的因素

全球霉浆菌检测市场正经历显着增长，这主要得益于生物技术和製药行业研发需求的不断增长，尤其是疫苗和细胞疗法等生物製药开发需求的日益增加。随着研究人员在生产过程中越来越依赖细胞株，确保这些细胞株係不含霉浆菌污染至关重要。企业越来越重视研发活动的品质保证，从而推动了对严格检测方法的需求。这种对维持高标准研发营运的日益重视，进一步刺激了对霉浆菌检测服务的需求。

限制全球霉浆菌检测市场的因素

全球霉浆菌检测市场面临的主要挑战之一是缺乏精通现代调查方法的专业技术人员。有效的霉浆菌检测依赖先进技术，而这些技术需要专业的知识和技能。缺乏训练有素的人员会阻碍这些检测方案的广泛应用。在资源和培训计画有限的开发中国家，这个问题尤其突出，进一步加剧了技能差距。因此，这可能会阻碍霉浆菌检测产业的整体发展和成长，并限制其在各个地区的潜力。

全球霉浆菌检测市场趋势

全球霉浆菌检测市场正呈现检查室操作自动化程度显着提高的趋势。自动化系统透过大幅缩短检测时间、提高生产效率和最大限度地减少人为错误，正在革新霉浆菌检测。这项转变的驱动力在于生物製药公司日益重视提高营运效率和维持流程品质的稳定性。随着这些公司寻求可靠、快速的检测解决方案，对先进霉浆菌检测技术的需求持续成长，巩固了自动化作为市场发展和转型关键驱动力的地位。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析

全球霉浆菌检测市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
• 试剂盒和试剂
  • PCR检测
  • 核酸检测试剂盒
  • 染料
  • 拆卸工具包
  • 标准与控制
  • 其他的
• 服务

全球霉浆菌检测市场规模（依技术及复合年增长率划分）（2026-2033 年）

• PCR
• ELISA
• 直接法
• 间接法
• 微生物培养技术
• 酵素法

全球霉浆菌检测市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 细胞株检测
• 病毒检测
• 停止细胞测试
• 其他的

全球霉浆菌检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 学术研究机构
• 细胞库
• 合约研究机构
• 製药和生物技术公司
• 其他的

全球霉浆菌检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Lonza Group Ltd.（Switzerland）
• Charles River Laboratories International Inc.（USA）
• Eurofins Scientific SE（Luxembourg）
• Roche Diagnostics（Switzerland）
• Agilent Technologies Inc.（USA）
• Bio-Rad Laboratories Inc.（USA）
• Sartorius AG（Germany）
• bioMerieux SA（France）
• Asahi Kasei Corporation（Japan）
• American Type Culture Collection（ATCC）（USA）
• Bionique Testing Laboratories Inc.（USA）
• InvivoGen（USA）
• PromoCell GmbH（Germany）
• Biological Industries Israel Beit Haemek Ltd.（Israel）
• Creative Bioarray（USA）
• Mycoplasma Experience（UK）
• Norgen Biotek Corp.（Canada）
• Biotools B & M Labs SA（Spain）

结论与建议

Global Mycoplasma Testing Market size was valued at USD 897.33 Million in 2024 and is poised to grow from USD 967.32 Million in 2025 to USD 1764.09 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The mycoplasma testing market is poised for significant growth, driven by rising contamination incidents in the pharmaceutical and biotechnology sectors. The demand for mycoplasma testing kits is notably increasing, fueled by intensified research initiatives and the biopharmaceutical industry's requirements. Emerging markets are contributing to this growth due to improved healthcare infrastructure, unmet healthcare needs, and a higher prevalence of mycoplasma contamination. Regulatory bodies are enforcing stringent testing mandates for biologics and vaccines, further fueling demand in the biopharmaceutical arena. Additionally, advancements in technology are enhancing the market, introducing faster and more accurate testing methods. Notable innovations include highly sensitive assays, improving detection in biological matrices and reinforcing the importance of effective mycoplasma testing solutions in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segments Analysis

Global Mycoplasma Testing Market is segmented by Product, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Kits & Reagents and Services. Based on Technology, the market is segmented into PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing and Others. Based on End-User, the market is segmented into Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycoplasma Testing Market

The global market for mycoplasma testing is experiencing significant growth, primarily fueled by the rising demand for research and development in the biotechnology and pharmaceutical sectors, particularly in the creation of biological products, such as vaccines and cell-based therapies. As researchers increasingly depend on cell lines for their manufacturing processes, ensuring that these cell lines are free from mycoplasma contamination has become essential. Companies are placing a greater emphasis on quality assurance in their research activities, driving the need for stringent testing methods. This increased focus on maintaining high standards in research operations is further propelling the demand for mycoplasma testing services.

Restraints in the Global Mycoplasma Testing Market

One significant challenge facing the global mycoplasma testing market is the shortage of skilled professionals proficient in contemporary testing methodologies. Effective mycoplasma testing relies on advanced techniques that necessitate specialized knowledge and expertise. The insufficient availability of adequately trained personnel can impede the widespread adoption and implementation of these testing solutions. This issue is particularly pronounced in developing countries, where access to resources and training programs is often limited, further exacerbating the skill gap. As a result, the overall progress and growth of the mycoplasma testing industry may be adversely affected, hindering its potential in various regions.

Market Trends of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant trend towards the integration of automation in laboratory operations. Automated systems are revolutionizing mycoplasma testing by drastically reducing testing times, enhancing productivity, and minimizing human errors. This shift is propelled by the increasing focus of biopharmaceutical companies on improving operational efficiency and maintaining consistent quality in their processes. As these companies seek reliable and rapid testing solutions, the demand for advanced mycoplasma testing technologies continues to grow, solidifying the role of automation as a key driver in the market's evolution and transformation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Mycoplasma Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Global Mycoplasma Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Global Mycoplasma Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Global Mycoplasma Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Global Mycoplasma Testing Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations